ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07725
0,00%
Bitcoin
63.380,80
-0,80%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. ClearPoint Neuro Inc (CLPT)

  7. ClearPoint Neuro Inc (CLPT) News

CLPT ClearPoint Neuro Inc

5,94
0,42 (7,61%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
ClearPoint Neuro Inc CLPT NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,42 7,61% 5,94 06:00:02
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
5,59 5,59 5,88 5,87 5,52
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.5.202422:05GLOBEClearPoint Neuro to Present Novel Research and Exhibit at..
29.4.202414:00GLOBEClearPoint Neuro Announces FDA Clearance of Prism Bone..
24.4.202422:05GLOBEClearPoint Neuro Announces Initiation of Limited Market..
23.4.202422:05GLOBEClearPoint Neuro to Announce First Quarter 2024 Results May..
16.4.202422:05GLOBEClearPoint Neuro Congratulates its Partner AviadoBio on..
19.3.202413:07GLOBEClearPoint Neuro Congratulates its Partner PTC Therapeutics..
12.3.202421:05GLOBEClearPoint Neuro Reports Fourth Quarter and Full-Year 2023..
11.3.202413:00GLOBEJournal of Neurosurgery Publication Demonstrates Distinct..
08.3.202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202422:05GLOBEClearPoint Neuro to Announce Fourth Quarter and Full Year..
01.3.202414:00EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
29.2.202414:00GLOBEClearPoint Neuro Announces Pricing of Public Offering of..
28.2.202422:45GLOBEClearPoint Neuro Launches Proposed Public Offering of Common..
24.2.202400:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202422:05GLOBEClearPoint Neuro Announces FDA Clearance and First-in-Human..
06.2.202422:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24.1.202422:05GLOBEClearPoint Neuro Announces Installation and First Procedure..
22.1.202422:05GLOBEClearPoint Neuro Announces First EU MDR Certification..
16.1.202414:00GLOBEClearPoint Neuro Announces FDA Clearance for SmartFrame OR™..
08.1.202422:07EDGAR2Form 8-K - Current report
08.1.202422:05GLOBEClearPoint Neuro Reports Fourth Quarter and Full Year 2023..
04.1.202402:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202402:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202402:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202402:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202417:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202417:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.11.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
13.11.202315:22EDGAR2Form S-3 - Registration statement under Securities Act of..
09.11.202323:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202322:05GLOBEClearPoint Neuro Reports Third Quarter 2023 Results
26.10.202322:05GLOBEClearPoint Neuro to Announce Third Quarter 2023 Results..
12.10.202320:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.10.202318:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.10.202318:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.10.202318:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.8.202322:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.8.202323:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.8.202322:06EDGAR2Form 8-K - Current report
08.8.202322:05GLOBEClearPoint Neuro Reports Second Quarter 2023 Results
01.8.202322:48EDGAR2Form 8-K - Current report
25.7.202322:05GLOBEClearPoint Neuro to Announce Second Quarter 2023 Results..
11.7.202322:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.7.202318:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.7.202323:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.7.202323:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.7.202323:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NASDAQ
CLPT
ClearPoint Neuro
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten